Evidence map›Paper›PMID 25803847›Full record

ArticlePloS one2015

Effect of the transient pharmacological inhibition of Mapk3/1 pathway on ovulation in mice.

Dayananda Siddappa, Élaine Beaulieu, Nicolas Gévry, Philippe P Roux, Vilceu Bordignon, Raj Duggavathi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Expression of ERK1/2 in Female Yak (Animals : an open access journal from MDPI · 2020
    Article
  14. Article
  15. Article
  16. Oncotarget · 2017
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Dayananda SiddappaDepartment of Animal Science, McGill University, Ste-Anne-de-Bellevue, QC H9X 3V9, Canada.
Élaine BeaulieuDépartement de Biologie, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
Nicolas GévryDépartement de Biologie, Université de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
Philippe P RouxInstitute for Research in Immunology and Cancer, Faculty of Medicine, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Vilceu BordignonDepartment of Animal Science, McGill University, Ste-Anne-de-Bellevue, QC H9X 3V9, Canada.
Raj DuggavathiDepartment of Animal Science, McGill University, Ste-Anne-de-Bellevue, QC H9X 3V9, Canada.
McGill University · CAUniversité de Sherbrooke · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitogen-activated protein kinase 3/1 (Mapk3/1) pathway is critical for LH signal transduction during ovulation. However, the mechanisms remain incompletely understood. We hypothesized that Mapk pathway regulates ovulation through transcriptional regulation of ovulatory genes. To test this hypothesis we used immature mice superovulated with equine and human chorionic gonadotropins (eCG and hCG) and PD0325901, to inhibit hCG-induced Mapk3/1 activity. Mice received either the inhibitor PD0325901 (25 μg/g, i.p.) or vehicle at 2h before hCG stimulation. Administration of the inhibitor abolished Mapk3/1 phosphorylation in granulosa cells. While vehicle-treated mice ovulated normally, there were no ovulations in inhibitor-treated mice. First, we analyzed gene expression in granulosa cells at 0h, 1h and 4h post-hCG. There was expected hCG-driven increase in mRNA abundance of many ovulation-related genes including Ptgs2 in vehicle-treated granulosa cells, but not (P<0.05) in inhibitor-treated group. There was also reduced mRNA and protein abundance of the transcription factor, early growth response 1 (Egr1) in inhibitor-treated granulosa cells. We then used GRMO2 cell-line to test if Egr1 is recruited to promoter of Ptgs2 followed by chromatin immunoprecipitation with either Egr1 or control antibody. Enrichment of the promoter regions in immunoprecipitants of Egr1 antibody indicated that Egr1 binds to the Ptgs2 promoter. We then knocked down Egr1 expression in mouse primary granulosa cells using siRNA technology. Treatment with Egr1-siRNA inhibited Egr1 transcript accumulation, which was associated with reduced expression of Ptgs2 when compared to control-siRNA treated granulosa cells. These data demonstrate that transient inhibition of LH-stimulated MAPK3/1 activity abrogates ovulation in mice. We conclude that Mapk3/1 regulates ovulation, at least in part, through Egr1 and its target gene, Ptgs2 in granulosa cells of ovulating follicles in mice.

Indexed as

AnimalsBenzamidesCyclooxygenase 2DiphenylamineEarly Growth Response Protein 1FemaleGonadotropinsGranulosa CellsHorsesHumansMAP Kinase Signaling SystemMiceMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Ovarian FollicleOvulationBenzamidesCyclooxygenase 2DiphenylamineEarly Growth Response Protein 1Egr1 protein, mouseGonadotropinsmirdametinibMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Protein Kinase InhibitorsPtgs2 protein, mouse

Identifiers

PMID25803847
PMCPMC4372293
OpenAlexW2083501031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.